Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | STMN1 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
mRNA | SEPT5 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
mRNA | UNC80 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
mRNA | PIGN | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
mRNA | CLVS1 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
mRNA | WDTC1 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
mRNA | HCFC1 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
mRNA | ZNF785 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
mRNA | CEP55 | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
mRNA | SP4 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |